MedPath

Evaluating the effects of thermotherapy on cutaneous leishmaniasis

Phase 2
Conditions
Cutaneous leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT138903183862N5
Lead Sponsor
Research Council of Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
35
Inclusion Criteria

confirmed cutaneous leishmaniasis by direct smear, less than 6 months of clinical duration, ulcer size less than 1 cm that limits topical application thermotherapy, signing of inform consent form for using this treatment modalities. Exclusion criteria: presence of lesion in sensitive sites to thermotherapy, patients who under simultaneous treatment for cutaneous leishmaniasis.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion healing. Timepoint: weekly. Method of measurement: measuring the size of induration and ulcer by caliper.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: weekly. Method of measurement: clinical evaluation.
© Copyright 2025. All Rights Reserved by MedPath